i8-k.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549


FORM 8-K


CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934


Date of report (Date of earliest event reported):   June 15, 2009


INSMED INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)

Virginia
(State or Other Jurisdiction of Incorporation)
 
0-30739
54-1972729
(Commission File Number)
(IRS Employer Identification No.)
       
8720 Stony Point Parkway, Suite 200, Richmond, Virginia
23235
(Address of Principal Executive Offices)
(Zip Code)

 
(804) 565-3000
(Registrant’s Telephone Number, Including Area Code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o                 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o                 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o                 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o                 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
INFORMATION TO BE INCLUDED IN THE REPORT

Section 5—Corporate Governance and Management

Item 5.02
Departure of Directors or Principal Officers: Election of Directors, Appointment of Principal Officers.
 
On June 15, 2009 the company issued a press release announcing the resignation of Dr. Geoffrey Allan as Insmed’s President, Chief Executive Officer and Chairman of the Board of Directors, effective immediately, due to a health condition and that Dr. Melvin Sharoky had been appointed Chairman of the Board of Directors. A copy of the press release is attached hereto as Exhibit 99.1

Item 9.01
Financial Statements and Exhibits

(d)  Exhibits
 
Exhibit No.     Description
 
99.1
Press Release issued by Insmed Incorporated on June 15, 2009
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
Insmed Incorporated
   
   
        Date: June 19, 2009
  
 
By:  /s/ Kevin P. Tully
 
Name:  Kevin P. Tully C.G.A.,
 
Title:  Executive Vice President & Chief Financial Officer
 
   
 



 
EXHIBIT INDEX
 
   
    Exhibit No.
Description
    99.1
Press Release, dated June 15, 2009